Предикторы Развития Сахарного Диабета 1 Типа У Детей И Подростков

Корнева, К.Г.; России, Фгбоу Во Пиму Минздрава; Стронгин, Л Г; Колбасина, Е.В; Будылина, М.В; Makeeva, Nadezda; Загайнов, В.Е.; больница, Гбуз Но Нижегородская областная детская клиническая; Республики, Бу Республиканская детская клиническая больница Минздрава Чувашской; больница, Гбу Рмэ Детская республиканская клиническая

doi:10.14341/conf22-25.09.21-142

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diabetic bullosis (diabetic bullosis, bullosis diabeticorum, diabetic bullae) is a dermatosis that occurs in patients with diabetes and is characterized by a rash of subepidermal blisters, most often localized on the anterior surfaces of the legs [29,30]. In modern literature, descriptions of combinations of dermatopathies with other complications of diabetes are extremely rare, and we have not come across any mention of a combination of common DNOAP and diabetic bullosis [31,32,33,34,35]. TARGET.…”

Section: Introductionmentioning

confidence: 99%

Features of the Course of Diabetic Neurosteoarthropathy in Patients With Type 2 Diabetes Mellitus

Aramovna,

Sevara,

Feruza

et al. 2023

JMGCB

View full text Add to dashboard Cite

Diabetic neuroosteoarthropathy (DNOA, Charcot foot) is a relatively rare complication of diabetes mellitus (DM), which can lead not only to impaired support function of the lower limb in such patients, but also to high amputation. DNOAP is characterized by persistent aseptic inflammation of the bone structures of the foot, which creates significant difficulties in planning treatment measures[1,2,3,4]. In the medical literature, there is data demonstrating the role of individual cytokines and neurohumoral factors in the prolongation of the inflammatory process in diabetes, however, studies identifying significant markers Aseptic inflammation with DNOAP is currently extremely rare[5,6,7].

show abstract

Section: Introductionmentioning

confidence: 99%

Features of the Course of Diabetic Neurosteoarthropathy in Patients With Type 2 Diabetes Mellitus

Aramovna,

Sevara,

Feruza

et al. 2023

JMGCB

View full text Add to dashboard Cite

show abstract

“…Prevention of complications specific to NIDDM is key to reducing morbidity and mortality associated with diabetes [10,11]. In recent years, it has been shown that complications of diabetes are often diagnosed before the initial diagnosis of the disease itself, since 50% of cases of all patients have damage to other organs and tissues [30,31,32,35]. If diabetes is not detected or treated adequately, this inevitably leads to the occurrence of microvascular complications and an increase in the number of hospitalizations associated not only with diabetes, but also with the treatment of its complications [12][13][14][15].…”

Section: Introductionmentioning

confidence: 99%

Influence of Type 2 Diabetes on the Function of the Central Nervous System

Aramovna,

Muxlisa,

Elnura

et al. 2023

JMGCB

View full text Add to dashboard Cite

Diabetes mellitus (DM) is a global health problem that affects all age groups, races and ethnicities[1,3,4]. Currently, about 177 million people worldwide suffer from this disease[33,34]. According to WHO forecast, the number of patients with diabetes will increase to 300 million people by 2025[2,5,6]. Non-insulin-dependent diabetes mellitus (NIDDM) is the most common and accounts for about 90% of diabetes cases[7,8,9].

show abstract

Предикторы Развития Сахарного Диабета 1 Типа У Детей И Подростков

Cited by 2 publications

References 0 publications

Features of the Course of Diabetic Neurosteoarthropathy in Patients With Type 2 Diabetes Mellitus

Features of the Course of Diabetic Neurosteoarthropathy in Patients With Type 2 Diabetes Mellitus

Influence of Type 2 Diabetes on the Function of the Central Nervous System

Contact Info

Product

Resources

About